The genetic testing company 23andMe became a Silicon Valley sensation by providing consumers with health and ancestry information based on a sample of their saliva, but suffered a setback when the Food and Drug Administration told it to stop presenting health data in 2013

Quick Read

Study to collect data from customers of genetic-testing services

Quick Read

How much would you pay to know your genetic code? Some companies are willing to lose money to find out

Quick Read

One of the top providers of gene-sequencing technology, Illumina, is teaming up with investors in hopes of buttressing the growing universe of genetic analysis businesses

Quick Read

The Doctor Is Out

April 23, 2015

Consumers will soon be able to bypass their doctors by going online to order cholesterol readings, thyroid tests and other bloodwork from the biggest diagnostics company in the US

Quick Read

Our Leila Jamal argues that, “we must keep the big picture in sight, and not let a tiff between the FDA and 23andMe hinder creative new ways of communicating and teaching about human genomics”

Read More

Reluctance to return results has less to do with questioning people’s ability to understand uncertain risk than the irresponsibility of giving out info that doctors and researchers don’t fully understand themselves

Read More

Pogo said, “We have met the enemy and he is us”. Questionable grammar aside, we as a society invite this type of problem by allowing advertisers to trade on the implicit trust we have in medical professionals

Read More